Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

August 5, 2020

The discovery of SWI/SNF chromatin remodeling activity as a novel and targetable dependency in uveal melanoma

Molecular Cancer Therapeutics
Florencia RagoZainab Jagani
June 5, 2020
Open Access

Dose-dependent functions of SWI/SNF BAF in permitting and inhibiting cell proliferation in vivo

Science Advances
Aniek van der VaartSander van den Heuvel
June 20, 2020
Preprint
Open Access

Association of Assisted Reproductive Technologies with offspring cord blood DNA methylation across cohorts.

MedRxiv : the Preprint Server for Health Sciences
Doretta CaramaschiH. Elliott
June 7, 2020
Review
Open Access

HMGA Proteins in Hematological Malignancies

Cancers
Angela MinerviniFrancesco Albano
July 4, 2020
Preprint
Open Access

BRG1 promotes transcriptional patterns that are permissive to proliferation in cancer cells

BioRxiv : the Preprint Server for Biology
K. A. GilesPhillippa C Taberlay
August 2, 2020

Remodeling of the ARID1A tumor suppressor

Cancer Letters
Qingyu LuoZhihua Liu
June 9, 2020
Open Access

ZSCAN4 facilitates chromatin remodeling and promotes the cancer stem cell phenotype

Oncogene
Benjamin A PortneyMichal Zalzman
July 31, 2020

Long non-coding RNA (lncRNA) and epithelial-mesenchymal transition (EMT) in colorectal cancer: a systematic review

Cancer Biology & Therapy
Stephen J O'BrienSusan Galandiuk
June 20, 2020
Review

The epigenetics of brain tumors and its modulation during radiation: A review

Life Sciences
Raghavi RavirajDevipriya Nagarajan

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

© 2020 Meta ULC. All rights reserved
/feed-previews/cancer-epigenetics-and-chromatin/4c37d19c-6d58-4ab4-b569-edb7b1810c0f